Back to mobile site

Piper Sandler Starts UroGen Pharma (URGN) at Overweight

August 18, 2025 4:19 PM EDT Send to a Friend
(Updated - August 19, 2025 6:18 AM EDT)

Piper Sandler analyst Kelsey Goodwin initiates coverage on UroGen Pharma (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login